152 related articles for article (PubMed ID: 33647882)
1. Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα.
Wang Y; Xie W; Hou M; Tian J; Zhang X; Ren Q; Huang Y; Chen J
Aging (Albany NY); 2021 Mar; 13(8):11026-11042. PubMed ID: 33647882
[TBL] [Abstract][Full Text] [Related]
2. Differential ability of formononetin to stimulate proliferation of endothelial cells and breast cancer cells via a feedback loop involving MicroRNA-375, RASD1, and ERα.
Chen J; Zhang X; Wang Y; Ye Y; Huang Z
Mol Carcinog; 2018 Jul; 57(7):817-830. PubMed ID: 29722068
[TBL] [Abstract][Full Text] [Related]
3. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J
J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683
[TBL] [Abstract][Full Text] [Related]
4. Correction for: Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα.
Wang Y; Xie W; Hou M; Tian J; Zhang X; Ren Q; Huang Y; Chen J
Aging (Albany NY); 2022 Mar; 14(5):2434-2435. PubMed ID: 35288485
[No Abstract] [Full Text] [Related]
5. Inhibitory effect of calycosin on breast cancer cell progression through downregulating lncRNA HOTAIR and downstream targets: HuR and IGF2BP1.
Li Y; Miao H; Wei W; Tian J; Chen J
Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 55(2):225-236. PubMed ID: 36647722
[TBL] [Abstract][Full Text] [Related]
6. Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo.
Chen J; Liu L; Hou R; Shao Z; Wu Y; Chen X; Zhou L
Cancer Lett; 2011 Sep; 308(2):144-51. PubMed ID: 21612861
[TBL] [Abstract][Full Text] [Related]
7. Calycosin and genistein induce apoptosis by inactivation of HOTAIR/p-Akt signaling pathway in human breast cancer MCF-7 cells.
Chen J; Lin C; Yong W; Ye Y; Huang Z
Cell Physiol Biochem; 2015; 35(2):722-8. PubMed ID: 25613518
[TBL] [Abstract][Full Text] [Related]
8. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
Chen J; Hou R; Zhang X; Ye Y; Wang Y; Tian J
PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835
[TBL] [Abstract][Full Text] [Related]
9. Formononetin promotes proliferation that involves a feedback loop of microRNA-375 and estrogen receptor alpha in estrogen receptor-positive cells.
Chen J; Zhang X; Wang Y; Ye Y; Huang Z
Mol Carcinog; 2016 Mar; 55(3):312-9. PubMed ID: 25663261
[TBL] [Abstract][Full Text] [Related]
10. Biochanin A promotes proliferation that involves a feedback loop of microRNA-375 and estrogen receptor alpha in breast cancer cells.
Chen J; Ge B; Wang Y; Ye Y; Zeng S; Huang Z
Cell Physiol Biochem; 2015; 35(2):639-46. PubMed ID: 25613180
[TBL] [Abstract][Full Text] [Related]
11. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Sun H; Yin M; Qian W; Yin H
Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
[TBL] [Abstract][Full Text] [Related]
12. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
13. Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.
Andruska N; Zheng X; Yang X; Helferich WG; Shapiro DJ
Oncogene; 2015 Jul; 34(29):3760-9. PubMed ID: 25263449
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin.
Chen J; Zhao X; Ye Y; Wang Y; Tian J
Cell Physiol Biochem; 2013; 32(6):1790-7. PubMed ID: 24355881
[TBL] [Abstract][Full Text] [Related]
15. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
16. Calycosin inhibits nasopharyngeal carcinoma cells by influencing EWSAT1 expression to regulate the TRAF6-related pathways.
Kong L; Li X; Wang H; He G; Tang A
Biomed Pharmacother; 2018 Oct; 106():342-348. PubMed ID: 29966979
[TBL] [Abstract][Full Text] [Related]
17. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
18. Calycosin induces apoptosis by upregulation of RASD1 in human breast cancer cells MCF-7.
Tian J; Duan YX; Bei CY; Chen J
Horm Metab Res; 2013 Aug; 45(8):593-8. PubMed ID: 23609007
[TBL] [Abstract][Full Text] [Related]
19. Calycosin Inhibits the Migration and Invasion of Human Breast Cancer Cells by Down-Regulation of Foxp3 Expression.
Li S; Wang Y; Feng C; Wu G; Ye Y; Tian J
Cell Physiol Biochem; 2017; 44(5):1775-1784. PubMed ID: 29241196
[TBL] [Abstract][Full Text] [Related]
20. Novel role of BRCA1 interacting C-terminal helicase 1 (BRIP1) in breast tumour cell invasion.
Rizeq B; Sif S; Nasrallah GK; Ouhtit A
J Cell Mol Med; 2020 Oct; 24(19):11477-11488. PubMed ID: 32888398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
